The estimated Net Worth of Carrie C Strom is at least $12.6 million dollars as of 16 February 2023. Carrie Strom owns over 28,541 units of Abbvie Inc stock worth over $7,379,047 and over the last 5 years Carrie sold ABBV stock worth over $5,255,916.
Carrie has made over 4 trades of the Abbvie Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Carrie sold 28,541 units of ABBV stock worth $4,310,833 on 16 February 2023.
The largest trade Carrie's ever made was selling 28,541 units of Abbvie Inc stock on 16 February 2023 worth over $4,310,833. On average, Carrie trades about 1,913 units every 31 days since 2020. As of 16 February 2023 Carrie still owns at least 37,921 units of Abbvie Inc stock.
You can see the complete history of Carrie Strom stock trades at the bottom of the page.
Carrie's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Over the last 12 years, insiders at Abbvie Inc have traded over $324,915,370 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 . The most active insiders traders include Richard A Gonzalez, Frederick H Waddell et Glenn F Tilton. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $7,529,855. The most recent stock trade was executed by Richard A Gonzalez on 5 August 2024, trading 66,500 units of ABBV stock currently worth $12,403,580.
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
Abbvie Inc executives and other stock owners filed with the SEC include: